Achilles Therapeutics Plc Operating Income

Achilles Therapeutics Plc (ACHL) currently reports a operating income of $-72M as of September 2024. That compares with $-79M in the prior-year period — up 8.1% year over year. Use the charts on this page to explore Achilles Therapeutics Plc's operating income history and peer comparisons.

Achilles Therapeutics Plc's operating income increased from $-79M to $-72M — a 8.1% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Achilles Therapeutics Plc reported $-72M in operating income as of September 2024. That compares with $-79M in the prior-year period — up 8.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-72M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Achilles Therapeutics Plc, and consider following ACHL for alerts when major investors trade the stock.

Achilles Therapeutics Plc is classified in the Healthcare sector. On operating income, it currently shows $-72M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACHL with unrelated industries.